Edward M. MD Kaye - 27 Mar 2023 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role
CEO, Director
Signature
/s/ Stephen Tulipano, Attorney-in-Fact
Issuer symbol
STOK
Transactions as of
27 Mar 2023
Transactions value $
$12,000
Form type
4
Filing time
08 Sep 2023, 17:15:39
Previous filing
17 Mar 2023
Next filing
05 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STOK Common Stock Options Exercise $12K +20K +80% $0.60 45K 27 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STOK Employee Stock Option (right to buy) Options Exercise $0 -20K -3.21% $0.00 603K 27 Mar 2023 Common Stock 20K $0.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested as to 1/4th of the total shares on October 17, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.